Adjuvant therapy for stage II colon cancer: A systematic review from the cancer care Ontario program in evidence-based care's gastrointestinal cancer disease site group

Journal of Clinical Oncology

Volumn 22, Issue 16, 2004, Pages 3395-3407

  Figueredo, Alvaro ^a   Charette, Manya L ^a   Maroun, Jean ^a   Brouwers, Melissa C ^a   Zuraw, Lisa ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

AWARENESS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONFIDENCE INTERVAL; EVIDENCE BASED MEDICINE; GENERAL CONDITION IMPROVEMENT; HEALTH PROGRAM; HUMAN; INFUSION; MULTIVARIATE ANALYSIS; OBSERVATION; PATIENT CARE; PORTAL VEIN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; UNITED STATES; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COLON TUMOR; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; META ANALYSIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 4344591790     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.03.087     Document Type: Review

References (56)

1. Nauta R, Stablein DM, Holyoke ED: Survival of patients with stage B2 colon carcinoma: The Gastrointestinal Tumour Study Group Experience. Arch Surg 124:180-182, 1989
2. Galandiuk S, Wieand HS, Moertel CG, et al: Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174:27-32, 1992
3. NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450, 1990
4. Figueredo A, Germond C, Maroun J, et al: Adjuvant therapy for stage II colon cancer after complete resection. Cancer Prev Control 1:379-392, 1997
5. Browman GP, Levine MN, Mohide EA, et al: The practice guidelines development cycle: A conceptual tool for practice guidelines development and implementation. J Clin Oncol 13:502-512, 1995
6. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC: Adjuvant therapy of colorectal cancer: Why we still don't know. JAMA 259:3571-3578, 1988
7. Parmar MKB, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-2834, 1998
8. Sinclair JC, Bracken MB: Clinically useful measures of effect in binary analyses of randomized trials. J Clin Epidemiol 47:881-889, 1994
9. DerSimonian R, Laird N: Meta-analyses in clinical trials. Control Clin Trials 7:177-188, 1986
10. Panettiere FJ, Goodman PJ, Costanzi JJ, et al: Adjuvant therapy in large bowel adenocarcinoma: Long-term results of a Southwest Oncology Group Study. J Clin Oncol 6:947-954, 1988
11. Wolmark N, Fisher B, Rockette H, et al: Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP protocol C-01. J Natl Cancer Inst 80:30-36, 1988
12. Windle R, Bell PR, Shaw D: Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Br J Surg 74:569-572, 1987
13. Laurie JA, Moertel CG, Fleming TR, et al: Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7:1447-1456, 1989
14. Moertel CG, Fleming TR, Macdonald JS, et al: Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 13:2936-2943, 1995
15. Taal BG, Van Tinteren H, Zoetmulder FA, et al: Adjuvant 5FU plus levamisole in colonic or rectal cancer: Improved survival in stage II and III. Br J Cancer 85:1437-1443, 2001
16. O'Connell MJ, Mailliard JA, Kahn MJ, et al: Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15:246-250, 1997
17. Francini G, Petrioli R, Lorenzini L, et al: Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106:899-906, 1994
18. Zaniboni A, Labianca R, Marsoni S, et al: GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma: Long term results and evaluation of the indicators of health-related quality of life. Cancer 82:2135-2144, 1998
19. Taylor I, Machin D, Mullee M, et al: A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 72:359-363, 1985
20. Fielding LP, Hittinger R, Grace RH, et al: Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma. Lancet 340:502-506, 1992
21. Beart RW Jr, Moertel CG, Wieand HS, et al: Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion: A study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg 125:897-901, 1990
22. Wereldsma JC, Bruggink ED, Meijer WS, et al: Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control: Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I). Cancer 65:425-432, 1990
23. Gray BN, deZwart J, Fisher R, et al: The Australia and New Zealand trial of adjuvant chemotherapy in colon cancer, in, Salmon SE (ed): Adjuvant Therapy of Cancer. New York, NY, Grune-Stratton, 1987, pp 537-554
24. Wolmark N, Rockette H, Wickerham DL, et al: Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: Preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol 8:1466-1475, 1990
25. Nitti D, Wils J, Sahmoud T, et al: Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). Eur J Cancer 33:1209-1215, 1997
26. Rougier P, Sahmoud T, Nitti D, et al: Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: A randomised trial. Lancet 351:1677-1681, 1998
27. James RD, on behalf of the AXIS collaborators: Intraportal 5FU (PVI) and peri-operative radiotherapy (RT) in the adjuvant treatment of colorectal cancer (CRCa): 3681 patients randomised in the UK Coordinating Committee on Cancer Res (UKCCCR) AXIS trial. Proc Am Soc Clin Oncol 18:264a, 1999 (abstr 1013)
28. Ryan J, Weiden P, Crowley J, et al: Adjuvant portal vein infusion for colorectal cancer: A 3-arm randomized trial. Proc Am Soc Clin Oncol 7:95, 1988 (abstr 361)
29. Swiss Group for Clinical Cancer Research (SAKK): Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet 345:349-353, 1995
30. Laffer U, Maibach R, Metzger U, et al: Randomized trial of adjuvant perioperative chemotherapy in radically resected colorectal cancer (SAKK 40/87). Proc Am Soc Clin Oncol 17:256a, 1998 (abstr 983)
31. Focan C, Bury J, Beauduin M, et al: Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: Results of a multicenter randomized trial. Anticancer Drugs 11:549-554, 2000
32. Schlag P, Saeger HD, Friedl P, et al: Adjuvant intraportal FUDR-chemotherapy in colon cancer patients, in Salmon SE (ed): Adjuvant Therapy of Cancer. New York, NY, Grune-Stratton, 1990, pp 439-445
33. Vaillant JC, Nordlinger B, Deuffic S, et al: Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. Ann Surg 231:449-456, 2000
34. Scheithauer W, Kornek G, Rosen H, et al: Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma. Eur J Cancer 31A:1981-1986, 1995
35. Graf W, Westlin JE, Pahlman L, et al: Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: A randomized phase II placebo-controlled study. Int J Colorectal Dis 9:35-39, 1994
36. Sadahiro S, Suzuki T, Tokunaga N, et al: Prophylactic hepatic arterial infusion chemotherapy for colon cancer patients without liver metastasis provides survival benefit. Proc Am Soc Clin Oncol 20:128a, 2001 (abstr 510)
37. Ito K, Yamaguchi A, Miura K, et al: Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: Five-year follow-up - Tokai HCFU Study Group: Third study on colorectal cancer. J Surg Oncol 63:107-111, 1996
38. Watanabe M, Nishida O, Kunii Y, et al: Clinical controlled trial on the efficacy of adjuvant chemotherapy for colon cancer: Results from cooperative project no. 15 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer. Proc Am Soc Clin Oncol 19:310a, 2000 (abstr 1224)
39. The Colorectal Cancer Chemotherapy Study Group of Japan: Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol 25:91-103, 1995
40. Hoover HC Jr, Brandhorst JS, Peters LC, et al: Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol 11:390-399, 1993
41. Vermerken JB, Claessen AM, Van Tinteren H, et al: Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial. Lancet 353:345-350, 1999
42. Harris JE, Ryan L, Hoover HC Jr, et al: Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol 18:148-157, 2000
43. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345:939-944, 1995
44. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators: Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 17:1356-1363, 1999
45. Gray R, James R, Mossman J, et al: AXIS: A suitable case for treatment. Br J Cancer 63:841-845, 1991
46. Liver Infusion Meta-analysis Group: Portal vein chemotherapy for colorectal cancer: A meta-analysis of 4000 patients in 10 studies. J Natl Cancer Inst 89:497-505, 1997
47. Sakamoto J, Hamada C, Kodaira S, et al: Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: Individual patient data meta-analysis of randomized trials. Jpn J Clin Oncol 29:78-86, 1999
48. Sakamoto J, Hamada C, Yasutomi M, et al: Adjuvant therapy with oral fluorinated pyrimidines after curative resection for colorectal cancer: Individual patient data meta-analysis of randomized trials. Proc Am Soc Clin Oncol 20:147a, 2001 (abstr 583)
49. Isenberg J, Ko H, Pulverer G, et al: Preoperative immunostimulation by Propionibacterium granulosum KP-45 in colorectal cancer. Anticancer Res 14:1399-1404, 1994
50. Dencausse Y, Hartung G, Sturm J, et al: Prospective randomized study of adjuvant therapy with edrecolomab (Panorex) of stage II colon cancer: Interim analysis. Proc Am Soc Clin Oncol 20:112b, 2001 (abstr 2198)
51. Gray R: Adjuvant therapy: How effective, and for which patients? A meta-analysis. Proc Eur Cancer Conf Abstract: 1997 (abstr 1297)
52. Zalcberg JR, Siderov J, Simes J: The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer. Ann Oncol 7:42-46, 1996
53. Sargent DJ, Goldberg RM, Jacobson SD, et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091-1097, 2001
54. Mamounas E, Wieand S, Wolmark N, et al: Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17:1349-1355, 1999
55. Gill S, Loprinzi CL, Sargent DJ, et al: Using a pooled analysis to improve the understanding of adjuvant therapy (AT) benefit for colon cancer (CC). Proc Am Soc Clin Oncol 22:261, 2003 (abstr 1014)
56. Buyse M, Piedbois P: Should Dukes' B patients receive adjuvant therapy? A statistical perspective. Semin Oncol 28:20-24, 2001